Peptides are back in the news. On October 30, 2026, the U.S. Department of Health and Human Services published a policy that lets licensed compounding pharmacies make six specific peptides again under strict conditions, and large pharmacies are announcing they will start filling them in December. If you live in Chesterfield or anywhere in West County and you have been reading about BPC-157, here is what changed, what did not, and how to get it from a provider instead of a website.
What changed
The new policy is called enforcement discretion. It means the FDA does not intend to act against qualifying compounding pharmacies that make six named peptides, BPC-157 among them, as long as they meet a list of conditions. Those conditions include filling only patient-specific prescriptions, working through state-licensed 503A pharmacies, sourcing from FDA-registered manufacturers with a certificate of analysis, and making single-ingredient products only.
What did not change
None of these peptides are FDA-approved. The policy does not add them to the official list of approved ingredients, and the FDA can revise or withdraw it at any time. Products sold online as “research use only” or “not for human consumption” are not covered, and they are not something a clinic should be handing you.
Why in person matters more now, not less
When a medication is not FDA-approved, three things carry most of the weight: who decides whether it is right for you, where it comes from, and who follows up afterward. An online questionnaire and a vial in the mail cover none of those well. At Ignite you meet our provider in person, get labs drawn, and if a peptide is appropriate for you, a state-licensed 503A pharmacy fills a prescription written for you by name. Your follow-up visits happen in the same building where you train.
How BPC-157 fits a program at Ignite
BPC-157 is a short peptide that has been studied mainly in laboratory and animal research for its possible role in tissue repair and recovery. Human research is limited, and nobody can promise a specific result. It sits alongside coached strength training, nutrition coaching and, where appropriate, hormone or GLP-1 therapy, so you get more out of it. Don’t just get a prescription. Get a program.
Common questions
Can I get BPC-157 in St. Louis?
Yes. Ignite offers BPC-157 when our provider decides it is appropriate for you, after an in-person visit and labs at our clinic in Chesterfield. It is compounded by a state-licensed 503A pharmacy and is not FDA-approved.
Is BPC-157 legal now?
Under the HHS policy published October 30, 2026, licensed 503A pharmacies may compound BPC-157 for an individual patient’s prescription when they meet the policy’s conditions. It is still not FDA-approved, and the policy can change.
Can I order it without seeing anyone?
Not from Ignite. Every peptide we offer starts with an in-person visit and labs with our provider.
Want to talk it through first? Book a 15-minute strategy call with Derek, or read more about peptide therapy at Ignite and how the full program works.
These peptides are compounded under a U.S. Department of Health and Human Services enforcement discretion policy. They are not FDA-approved drugs. Availability can change if that policy changes. Treatment is prescribed only when a licensed provider determines it is appropriate for you. Individual results vary.
